Launched in 2016, Promaxo plans to revolutionize healthcare with its MR imaging and robotic platform. Promaxo’s MRI is designed to be used in a standard physician’s office, without the need for extensive safety procedures or a dedicated infrastructure for housing and maintaining the unit. The Company is also developing a robotic system, which enables interventions directly under live MR image guidance, in OR settings or even in a physician’s office.
“We are thrilled to partner with Kineticos Disruptor Fund and leverage their market intelligence and commercialization expertise,” said Amit Vohra, President and CEO of Promaxo. “Our value proposition is unique – to make MRIs more versatile and accessible to patients and physicians.”
Funds from this investment will allow Promaxo to prepare for commercialization of its MRI in the urology market. The funds will be used for the continued development of Promaxo’s robotic and artificial intelligence programs.